This Kimball Electronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiated coverage on KE, MBX, ENSC, DORM and AGLT, issuing mostly Buy/positive ratings with new price targets.
Last updated: 2026-11-19 08:57:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
MBX Biosciences, Inc. (MBX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $53.52, with a market capitalization of $2.64B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $26.00 to $72.64. This page covers its latest market performance, valuation, price trends and company information.
$2.64B | |
$53.20 | |
$55.18 | |
$52.59 | |
$53.10 | |
607.91K | |
527.58K | |
-- | |
$72.64 | |
$26.00 | |
-- | |
2026-09-30 |
MBX Biosciences, Inc. (MBX) last closed at $53.52 as of 2026-11-19 00:31:00, up 0.68% ($0.36) from the previous close of $53.10.
During the latest regular trading session, MBX traded between $52.59 and $55.18, with a volume of 607.91K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, MBX Biosciences, Inc. (MBX) moved from $56.33 to $53.52, representing a decline of 4.99% ($2.81).
The stock traded between $50.22 and $58.56 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 618.91 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 59.0%
MBX is currently trading at $53.52, placing it 59.0% of the way from its 52-week low of $26.00 to its 52-week high of $72.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 63 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to MBX Biosciences, Inc. and MBX stock.
Analysts initiated coverage on KE, MBX, ENSC, DORM and AGLT, issuing mostly Buy/positive ratings with new price targets.
HC Wainwright & Co. analyst Mitchell S. Kapoor initiates coverage on MBX Biosciences (NASDAQ:MBX) with a Buy rating and announces Price Target of $90.
Eligible investors can buy real shares of MBX Biosciences, Inc. (MBX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MBX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between MBX shares and USD.
MBX Shares to USD
1.00 MBX shares = 53.52 USD
Calculations are estimates based on the latest available price and are for reference only.